Clinical Trial

VitaFlow™ II Transcatheter Aortic Valve System Pre-market Trial

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 4, 2020 (before its estimated January 31, 2022 completion). Its status may not reflect the trial's current state.
Summary
This is a pre-market clinical investigation aiming to evaluate the safety and effectiveness of Microport™ CardioFlow VitaFlow™ II Transcatheter Aortic Valve System for the treatment of severe aortic stenosis.
Trial Details
NCT Number NCT04414878
Lead Sponsor Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Conditions Aortic Stenosis
Enrollment 145 participants
Start Date 2018-01-31
Primary Completion 2022-01-31 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2020-06-04